Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the PRPF6 gene.
Features include always present findings: Constriction of peripheral visual field, Bone spicule pigmentation of the retina, Nyctalopia, and Reduced visual acuity and others; and common findings: Posterior subcapsular cataract and Optic disc pallor.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 5 | Visual impairment, Posterior subcapsular cataract, Optic disc pallor |
PRPF6 function has not been fully characterized.
Retinitis pigmentosa 60 is associated with mutations in the PRPF6 gene on chromosome 20.
Genetic testing for PRPF6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 60 has been reported in the published literature.
Phenotype severity distribution: 9 always present features, 2 common features.
No clinical trials have been registered for retinitis pigmentosa 60.
82 publications have been identified in PubMed for retinitis pigmentosa 60. Research spans Epidemiology / Natural History (39%), Case Report / Case Series (18%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 32 | 39% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:40 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Bones and joints |
1 |
Bone spicule pigmentation of the retina |
Muscles | 1 | Retinal pigment epithelial atrophy |
Patient case studies
15 |
18% |
Testing and diagnosis research | 11 | 13% |
Laboratory research | 11 | 13% |
Clinical study results | 6 | 7% |
New treatment approaches | 4 | 5% |
Research summaries | 3 | 4% |
Carpenter E (2026). [PMID: 41632744](https://pubmed.ncbi.nlm.nih.gov/41632744/). *Ophthalmic Res*. [Diagnostic / Biomarker]
Daich Varela M (2026). [PMID: 41660487](https://pubmed.ncbi.nlm.nih.gov/41660487/). *Ophthalmol Sci*. [Epidemiology / Natural History]
Kessel L (2026). [PMID: 42272130](https://pubmed.ncbi.nlm.nih.gov/42272130/). *Ophthalmic Genet*. [Epidemiology / Natural History]
Emanuelli A (2026). [PMID: 41826528](https://pubmed.ncbi.nlm.nih.gov/41826528/). *Doc Ophthalmol*. [Diagnostic / Biomarker]
Hisai T (2026). [PMID: 41140900](https://pubmed.ncbi.nlm.nih.gov/41140900/). *Ophthalmology science*. [Epidemiology / Natural History]
Zheng CY (2026). [PMID: 41804064](https://pubmed.ncbi.nlm.nih.gov/41804064/). *Ophthalmic Genet*. [Case Report / Case Series]
Li N (2026). [PMID: 41584402](https://pubmed.ncbi.nlm.nih.gov/41584402/). *Clin Case Rep*. [Case Report / Case Series]
Beaulieu C (2026). [PMID: 41954904](https://pubmed.ncbi.nlm.nih.gov/41954904/). *JAMA Ophthalmol*. [Basic Science / Preclinical]
Koizumi H (2026). [PMID: 41898848](https://pubmed.ncbi.nlm.nih.gov/41898848/). *Genes (Basel)*. [Case Report / Case Series]
Ruggeri ML (2026). [PMID: 42011186](https://pubmed.ncbi.nlm.nih.gov/42011186/). *Ther Adv Ophthalmol*. [Epidemiology / Natural History]